Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy

Abstract

Integration of gene expression signatures and clinical variables produced predictive models for prostate carcinoma recurrence that perform significantly better than those based on either clinical variables or gene expression information alone.